3 February 2012 - Ostial Solutions LLC, a US-based medical devices company focusing on the treatment of coronary and renal aorto-ostial disease, said on Thursday that it had sold all of its assets to Merit Medical Systems Inc (NASDAQ:MMSI) for an undisclosed amount.

Ostial Solutions' Ostial Pro Stent Positioning System has been approved for commercialisation in the US by the Food and Drug Administration (FDA), and Merit has already started shipping the product from its facilities.

Ostial Solutions was funded by a group of angel investors and the sale to Merit allowed these investors to realize the return on their investments, R. Kevin Plemmons, chief executive and president of Ostial Solutions, said.